FIELD: biotechnologies.
SUBSTANCE: method of obtaining of the patient (donor)-specific fibroblast-like cells from induced pluripotent human stem cells is described. Clusters of induced pluripotent stem cells are mechanically dissociated down to monocellular culture in presence of dispase. The cell suspension is placed in the medium consisting of the medium for cultivation of undifferentiated ES cells (mTeSr) + medium for cultivation of embryoid bodies (EB) (ET medium) in the ratio 1:1. Then embryoid bodies are obtained by the hanging drop method or by placing of cells into 96-pit round-bottom pad. Then three-day EBs are transferred to 24-pit die covered with 0.1% gelatine, one body per pit in 1 ml of medium for EB. They are cultivated until appearance of the monolayer of fibroblast-like cells after 8-10 days with preliminary removal of residue of the embryoid body.
EFFECT: invention allows to obtain donor- and patient-specific fibroblast-like cells for their use in transplantology and as autologous feeding layer for cultivation of induced pluripotent human stem cells and their maintaining in undifferentiated state.
10 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF INDUCED PLURIPOTENT HUMAN STEM CELLS FOR ASSESSING CITO- AND EMBRYOTOXIC PROPERTIES OF PHARMACOLOGICAL COMPOUNDS | 2015 |
|
RU2599847C1 |
METHOD FOR ASSESSING NEUROPROTECTIVE PROPERTIES OF VITRO SUBSTANCES AND THE TEST SYSTEM FOR ITS IMPLEMENTATION | 2016 |
|
RU2646446C1 |
METHOD OF OBTAINING CARDIOMYOCYTAL MATRIX | 2010 |
|
RU2430159C1 |
METHOD FOR OBTAINING ENDOTHELIOCYTES FROM HUMAN EMBRYONIC STEM CELLS (VERSIONS) | 2008 |
|
RU2359030C1 |
STIMULATION OF PATHWAY Wnt IN REPROGRAMMING SOMATIC CELLS | 2008 |
|
RU2492232C2 |
METHOD FOR PREPARING PLURIPOTENT CELLS | 2009 |
|
RU2399667C1 |
METHOD OF PRODUCING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLASTS OF PATIENTS WITH HUNTINGTON'S DISEASE | 2011 |
|
RU2458983C1 |
EVALUATION METHOD OF MORPHOFUNCTIONAL STATE OF INDUCED PLURIPOTENT STEM CELLS OF PARKINSONIAN PATIENTS, WHICH ARE DIFFERENTIATED TO DOPAMINERGIC NEURONS | 2012 |
|
RU2501853C1 |
TREATMENT OF DIABETES WITH HELP OF PANCREATIC ENDOCRINE PROGENITOR CELLS | 2011 |
|
RU2682719C2 |
METHODS OF DERIVING DIFFERENTIATED CELLS FROM STEM CELLS | 2009 |
|
RU2576003C2 |
Authors
Dates
2015-11-10—Published
2014-11-11—Filed